Literature DB >> 15328129

Quinolone-resistant Haemophilus influenzae in a long-term-care facility: nucleotide sequence characterization of alterations in the genes encoding DNA gyrase and DNA topoisomerase IV.

Xinying Li1, Noriel Mariano, James J Rahal, Carl M Urban, Karl Drlica.   

Abstract

Fluoroquinolone-resistant isolates of Haemophilus influenzae, obtained from a long-term care facility, were examined for nucleotide sequence differences in the quinolone-resistance-determining regions of gyrA, gyrB, parC, and parE. Similarities among the resistant isolates, plus multiple differences with susceptible isolates, suggest clonal dissemination involving two resistant subclones.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15328129      PMCID： PMC514738          DOI： 10.1128/AAC.48.9.3570-3572.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  14 in total

1.  Fluoroquinolone resistance in Haemophilus influenzae.

Authors:  Eugenne Elliott; Deon Oosthuizen; Maggie M Johnson; Laura J V Piddock
Journal:  J Antimicrob Chemother       Date:  2003-09-01       Impact factor: 5.790

2.  Activities and postantibiotic effects of gemifloxacin compared to those of 11 other agents against Haemophilus influenzae and Moraxella catarrhalis.

Authors:  T A Davies; L M Kelly; D B Hoellman; L M Ednie; C L Clark; S Bajaksouzian; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

3.  Detection of quinolone resistance in Haemophilus spp.

Authors:  J E Corkill; A Percival; P McDonald; A I Bamber
Journal:  J Antimicrob Chemother       Date:  1994-11       Impact factor: 5.790

4.  Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

Authors:  D K Chen; A McGeer; J C de Azavedo; D E Low
Journal:  N Engl J Med       Date:  1999-07-22       Impact factor: 91.245

5.  Ciprofloxacin-resistant Haemophilus influenzae strains possess mutations in analogous positions of GyrA and ParC.

Authors:  M Georgiou; R Muñoz; F Román; R Cantón; R Gómez-Lus; J Campos; A G De La Campa
Journal:  Antimicrob Agents Chemother       Date:  1996-07       Impact factor: 5.191

6.  Long-term persistence of ciprofloxacin-resistant Haemophilus influenzae in patients with cystic fibrosis.

Authors:  J Campos; F Román; M Georgiou; C García; R Gómez-Lus; R Cantón; H Escobar; F Baquero
Journal:  J Infect Dis       Date:  1996-12       Impact factor: 5.226

7.  In vitro activities of garenoxacin (BMS-284756) against Haemophilus influenzae isolates with different fluoroquinolone susceptibilities.

Authors:  María Pérez-Vázquez; Federico Román; Belen Aracil; Rafael Cantón; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

8.  Ciprofloxacin-resistant Haemophilus influenzae infection in a patient with chronic lung disease.

Authors:  S L Barriere; J A Hindler
Journal:  Ann Pharmacother       Date:  1993-03       Impact factor: 3.154

9.  Five-year analysis of Haemophilus influenzae isolates with reduced susceptibility to fluoroquinolones: prevalence results from the SENTRY antimicrobial surveillance program.

Authors:  Douglas J Biedenbach; Ronald N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  2003-05       Impact factor: 2.803

10.  Quinolone-resistant Haemophilus influenzae in a long-term care facility: clinical and molecular epidemiology.

Authors:  Jawad Nazir; Carl Urban; Noriel Mariano; Janice Burns; Barbara Tommasulo; Carl Rosenberg; Sorana Segal-Maurer; James J Rahal
Journal:  Clin Infect Dis       Date:  2004-05-12       Impact factor: 9.079
View more
  15 in total

1.  Quinolone-resistant Haemophilus influenzae: determination of mutant selection window for ciprofloxacin, garenoxacin, levofloxacin, and moxifloxacin.

Authors:  Xinying Li; Noriel Mariano; James J Rahal; Carl M Urban; Karl Drlica
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

2.  Different modes of action of naphthyridones in gram-positive and gram-negative bacteria.

Authors:  Ed T Buurman; Kenneth D Johnson; Roxanne K Kelly; Kathy MacCormack
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

3.  Melting curve analysis for rapid detection of topoisomerase gene mutations in Haemophilus influenzae.

Authors:  Shigeki Nakamura; Katsunori Yanagihara; Yoshitomo Morinaga; Koichi Izumikawa; Masafumi Seki; Hiroshi Kakeya; Yoshihiro Yamamoto; Shimeru Kamihira; Shigeru Kohno
Journal:  J Clin Microbiol       Date:  2009-01-07       Impact factor: 5.948

4.  Genetic detection of quinolone resistance in Haemophilus parainfluenzae: Mutations in the quinolone resistance-determining regions of gyrA and parC.

Authors:  Dennis Ks Law; Michelle Shuel; Sadjia Bekal; Elizabeth Bryce; Raymond Sw Tsang
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

5.  Molecular characterization of fluoroquinolone resistance in nontypeable Haemophilus influenzae clinical isolates.

Authors:  Carmen Puig; José Manuel Tirado-Vélez; Laura Calatayud; Fe Tubau; Junkal Garmendia; Carmen Ardanuy; Sara Marti; Adela G de la Campa; Josefina Liñares
Journal:  Antimicrob Agents Chemother       Date:  2014-11-10       Impact factor: 5.191

Review 6.  Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.

Authors:  A Dalhoff
Journal:  Infection       Date:  2012-03-30       Impact factor: 3.553

7.  Bactericidal activity of besifloxacin against staphylococci, Streptococcus pneumoniae and Haemophilus influenzae.

Authors:  Wolfgang Haas; Chris M Pillar; Christine K Hesje; Christine M Sanfilippo; Timothy W Morris
Journal:  J Antimicrob Chemother       Date:  2010-04-30       Impact factor: 5.790

8.  Use of gyrase resistance mutants to guide selection of 8-methoxy-quinazoline-2,4-diones.

Authors:  Nadezhda German; Muhammad Malik; Jonathan D Rosen; Karl Drlica; Robert J Kerns
Journal:  Antimicrob Agents Chemother       Date:  2008-09-02       Impact factor: 5.191

9.  In Vitro Derivation of Fluoroquinolone-Resistant Mutants from Multiple Lineages of Haemophilus influenzae and Identification of Mutations Associated with Fluoroquinolone Resistance.

Authors:  Hiroyuki Honda; Toyotaka Sato; Masaaki Shinagawa; Yukari Fukushima; Chie Nakajima; Yasuhiko Suzuki; Koji Kuronuma; Satoshi Takahashi; Hiroki Takahashi; Shin-Ichi Yokota
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

10.  Antimicrobial activities of piperacillin-tazobactam against Haemophilus influenzae isolates, including beta-lactamase-negative ampicillin-resistant and beta-lactamase-positive amoxicillin-clavulanate-resistant isolates, and mutations in their quinolone resistance-determining regions.

Authors:  Yoichi Hirakata; Kaori Ohmori; Miwako Mikuriya; Takeshi Saika; Kaoru Matsuzaki; Miyuki Hasegawa; Masumitsu Hatta; Natsuo Yamamoto; Hiroyuki Kunishima; Hisakazu Yano; Miho Kitagawa; Kazuaki Arai; Kazuyoshi Kawakami; Intetsu Kobayashi; Ronald N Jones; Shigeru Kohno; Keizo Yamaguchi; Mitsuo Kaku
Journal:  Antimicrob Agents Chemother       Date:  2009-08-03       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.